Amid The Perceived Gloom In The Hedge Fund Universe, This Hedge Fund's Stock Picks Gained 38.8% in Q1
The dismal performance, redemptions and shuttering of some hedge funds have received significant media attention in the past two years.
Sage Therapeutics Inc. (SAGE)
Market is closed
News
- First
- << Previous
- 41 - 50
- Next >>
Look: Sage Therapeutics (SAGE) breaks into new 52-week high
The biopharmaceutical company with a $2.74 billion market cap played around $69.50 to $73.60 on the trading charts, before it closed to $73.44. Most recently, Sage Therapeutics Inc.
5 Stocks The Best Performing Hedge Funds Are Piling Into
At Insider Monkey, we track more than 700 of the best hedge funds in the world and have developed various market-beating strategies over the years using the wealth of data we collect from their 13F filings...
Positive Results For MDD Drug Sends Shares Of SAGE Therapeutics Inc (SAGE) Soaring
Shares of SAGE Therapeutics Inc (NASDAQ:SAGE) surged after the results of a small, mid-stage study on major depressive disorder showed positive results.
How SAGE Therapeutics Inc (SAGE) Stacks Up Against Its Peers
Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.
SAGE Therapeutics Inc (SAGE): What Just Happened, And What's Next?
SAGE Therapeutics Inc (NASDAQ:SAGE) is running up on a trial update this week, with the company currently trading a little over 12% higher than its close on Friday.
Why Amazon, Starbucks and Three Other Stocks Are Trending Today
Among the newsworthy stocks amid the positive backdrop are Amazon.com, Inc.
Billionaire Ubben Buys More Shares of CBRE Group Inc. (CBG), Huber More Bullish on This Oil Tanker Stock, Plus Two Other Moves
Numerous sources and statistics recently indicated that hedge funds have been severely hit by the current volatile markets.
13G Filing: Visium Asset Management and Sage Therapeutics, Inc. (SAGE)
SAGE Therapeutics Inc (NASDAQ:SAGE) has recently been included in a filing by Jacob Gottlieb's Visium Asset Management.
The Smart Money Is Hoarding Shares of These 10 Healthcare Stocks: Part 1
Given elite hedge funds have filed their latest 13F's, we have an opportunity to analyze what hedge funds like and what they don't like.
- First
- << Previous
- 41 - 50
- Next >>
Billionaire Hedge Funds
